The company will not receive any of the proceeds from the sale by the selling stockholders of the shares of common stock.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHIO:
- Phio Pharmaceuticals: Promising Clinical Results and Strong Financial Position Justify Buy Rating
- Phio Pharmaceuticals Exercises Warrants for $13.4 Million
- 3 Penny Stocks to Watch Now, 11/4/25
- PHIO Upcoming Earnings Report: What to Expect?
- Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
